March 9, 2012 — Researchers say venom from the green mamba snake may aid in the preservation of cardiac and renal ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
March 7, 2012 — The U.S. Food and Drug Administration (FDA) notified healthcare professionals of updates to the ...
March 07, 2012
February 28, 2012 — Janssen Research and Development LLC announced that the U.S. Food and Drug Administration (FDA) has ...
February 28, 2012February 23, 2012 — AstraZeneca announced that the American College of Chest Physicians (ACCP) has updated its ...
February 23, 2012
February 20, 2012 — Biopharmaceutical company Celladon Corp. this week completed a $43 million equity financing to ...
February 20, 2012
January 19, 2012 – New findings from a research study led by physicians at Scripps Health reveal that the ...
January 19, 2012
January 9, 2012 – Janssen Research and Development, LLC (JRD) announced today that it has submitted a supplemental new ...
January 09, 2012
January 6, 2012 – People with high cholesterol are at risk of heart attack and stroke because atherosclerotic plaques ...
January 06, 2012
January 5, 2011 – Bayer HealthCare's oral anticoagulant tablet Xarelto (rivaroxaban) has been approved for use in the ...
January 05, 2012
December 20, 2011 – The U.S. Food and Drug Administration (FDA) completed a safety review of the anti-arrhythmia drug ...
December 20, 2011
December 5, 2011 – The U.S. Food and Drug Administration (FDA) approved the first generic version of the cholesterol ...
December 05, 2011
November 17, 2011 — Westside Medical Imaging of Beverly Hills announces the availability of high resolution magnetic ...
November 18, 2011
November 15, 2011 — A clinical trial comparing prasugrel to clopidogrel for patients with high on-clopidogrel platelet ...
November 15, 2011
November 15, 2011 — Results of ADAPT-DES (Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents) were ...
November 15, 2011
November 15, 2011 — Data from the BRIDGE clinical trial demonstrate that intravenous use of the drug cangrelor was ...
November 15, 2011